Key result
Targeting nitric oxide, prostacyclin, and endothelin pathways effectively manages PAH, typically requiring dual or triple therapy.
Why the study?
There has been significant evolution in therapies for PAH over 25 years, with a shift from 6-minute walk time to morbidity and mortality outcomes in trials, and uncertainty about optimal monotherapy versus combination therapy.
The management of PAH has shifted towards dual or triple combination therapy targeting the nitric oxide, prostacyclin, and endothelin pathways to reduce morbidity and mortality.
Answers are grounded in this paper and cite their sources.
Supports combination therapy in PAH; leaves open optimal sequencing and durability in broader populations.
Pulmonary arterial hypertension (PAH) is a condition associated with substantial morbidity and mortality. Over the last 25 years there has been a significant evolution in the therapies to treat PAH. These therapies are effective for patients with group I PAH and group IV PH [chronic thromboembolic pulmonary hypertension (CTEPH)]. PAH is characterized by an imbalance of nitric oxide, prostacyclin and endothelin levels, and current pharmacotherapy involves these three pathways. Earlier clinical trials involving PAH-specific therapies evaluated improvements in 6-minute walk time as a primary improvement whereas contemporary trials have been larger and focused on morbidity and mortality reductions. While there may be a role for monotherapy in disease management, most patients should be considered for dual or triple therapy.
No takes yet. Share an insight, caveat, or question.
Parikh et al. (2019) conducted a review in Pulmonary arterial hypertension (PAH). Pharmacotherapy (nitric oxide, prostacyclin, and endothelin pathway therapies) was evaluated. Pharmacotherapy targeting the nitric oxide, prostacyclin, and endothelin pathways is effective for pulmonary arterial hypertension, with most patients requiring dual or triple therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: